China, Sept. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Feasibility of a blood-based multi-cancer early detection test in screening population (NQMD-CS)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131406
Registration Time: 2026/09/02
Type: Observational study
Primary Sponsor: The Fifth Affiliated Hospital of Guangzhou Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338858
Published by HT Digital Content Services with permission from Health Daily Digest....